JP2023544836A5 - - Google Patents
Info
- Publication number
- JP2023544836A5 JP2023544836A5 JP2023521532A JP2023521532A JP2023544836A5 JP 2023544836 A5 JP2023544836 A5 JP 2023544836A5 JP 2023521532 A JP2023521532 A JP 2023521532A JP 2023521532 A JP2023521532 A JP 2023521532A JP 2023544836 A5 JP2023544836 A5 JP 2023544836A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063090440P | 2020-10-12 | 2020-10-12 | |
| US63/090,440 | 2020-10-12 | ||
| PCT/US2021/054437 WO2022081486A1 (en) | 2020-10-12 | 2021-10-11 | Cd19-directed chimeric antigen receptor constructs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023544836A JP2023544836A (ja) | 2023-10-25 |
| JP2023544836A5 true JP2023544836A5 (https=) | 2024-10-16 |
| JPWO2022081486A5 JPWO2022081486A5 (https=) | 2024-10-16 |
Family
ID=81209376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521532A Pending JP2023544836A (ja) | 2020-10-12 | 2021-10-11 | Ｃｄ１９に指向されたキメラ抗原受容体構築物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240261330A1 (https=) |
| EP (1) | EP4225799A4 (https=) |
| JP (1) | JP2023544836A (https=) |
| CN (1) | CN116601174A (https=) |
| WO (1) | WO2022081486A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4724492A1 (en) * | 2023-06-09 | 2026-04-15 | Antengene Biologics Limited | Novel antibodies targeting cd3 and another target and uses thereof |
| WO2026020171A2 (en) | 2024-07-19 | 2026-01-22 | Aera Therapeutics, Inc. | Chimeric antigen receptor constructs |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| WO2017070654A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
| WO2017172981A2 (en) * | 2016-03-29 | 2017-10-05 | University Of Southern California | Chimeric antigen receptors targeting cancer |
| US10875919B2 (en) * | 2016-04-26 | 2020-12-29 | Alector Llc | Chimeric receptors and methods of use thereof |
| CA3080109A1 (en) * | 2017-11-03 | 2019-05-09 | Sorrento Therapeutics, Inc. | Cd38-directed chimeric antigen receptor constructs |
| SG11202008568WA (en) * | 2018-03-09 | 2020-10-29 | Sorrento Therapeutics Inc | Dimeric antigen receptors (dar) |
| CA3125751A1 (en) * | 2019-01-07 | 2020-07-16 | Magenta Therapeutics, Inc. | Use of an anti-cd45 antibody drug conjugate (adc) in cell therapy |
| AU2020232691B2 (en) * | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| RU2742000C2 (ru) * | 2019-03-13 | 2021-02-01 | Общество С Ограниченной Ответственностью "Анабион" | Выделенный альтернативный внутриклеточный сигнальный домен химерного антигенного рецептора и включающий его химерный антигенный рецептор |
-
2021
- 2021-10-11 WO PCT/US2021/054437 patent/WO2022081486A1/en not_active Ceased
- 2021-10-11 US US18/248,079 patent/US20240261330A1/en active Pending
- 2021-10-11 CN CN202180083392.0A patent/CN116601174A/zh active Pending
- 2021-10-11 EP EP21880858.2A patent/EP4225799A4/en not_active Withdrawn
- 2021-10-11 JP JP2023521532A patent/JP2023544836A/ja active Pending